Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b...
FDA Recall #D-0113-2024 — Class III — October 27, 2023
Product Description
Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141.
Reason for Recall
Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
Recalling Firm
NCS Healthcare of Kentucky Inc — Glasgow, KY
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Product Quantity
1,344 cards
Distribution
Nationwide USA
Code Information
Lot#: a) 7718-3008, Exp 08/31/2024; b) 7718-3008, Exp 08/31/2024
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated